BELGRADE (Serbia), November 12 (SeeNews) - Serbia has agreed the delivery of 1.8 million units of the COVID-19 vaccine developed by US-based pharmaceutical company Pfizer and German biotechnology company BioNTech by the end of 2021, Serbian president Aleksandar Vucic said on Thursday.
"Through the Covax system, we have so far ensured the delivery of 1.8 million COVID-19 vaccine units for the end of this year and through the entire 2021. For now, it looks like that this vaccine will be the one of Pfizer and BioNTech, but we are also in talks with Chinese and Russian partners," Vucic said in a video streamed live at the YouTube channel of Tanjug news agency.
The Serbian government aims to ensure enough vaccine for all workers in its healthcare sector and a major part of police and armed forces by the end of January 2021, as they are most exposed to the virus, Vucic said.
"We will have the first vaccines in our country by the end of December," the president added.
Last month, Vucic said Serbia will sign a contract with Pfizer and BioNTech for the delivery of 350,000 doses of their COVID-19 vaccine by March 2021.